Buscar resultados de ensayos clínicos
Plaque, Atherosclerotic - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke Condición: Carotid Artery Plaque Fecha: 2015-01-26 |
Active, not recruiting |
Nombre del estudio: A Proposed Study of Atherosclerotic Plaques in Leg Arteries Condición:
Fecha: 2012-09-18 |
Completed |
Nombre del estudio: Identification of Genes Expressed in Atherosclerotic Plaque Condición: Atherosclerosis Fecha: 2006-07-18 |
Withdrawn |
Nombre del estudio: Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques Condición: Atherosclerosis Fecha: 2005-10-21 Intervenciones:
|
Withdrawn |
Nombre del estudio: Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque Condición: Acute Coronary Syndrome Fecha: 2008-09-25 Intervenciones:
|
Completed |
Nombre del estudio: Fractional Flow Reserve (FFR) Versus Instant Wave-Free Ratio (iFR) Condición:
Fecha: 2012-02-14 |
Completed |
Nombre del estudio: Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging Condición:
Fecha: 2009-06-12 Intervenciones:
|
Recruiting |
Nombre del estudio: The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis With Vulnerable Plaque Characteristics Condición:
Fecha: 2014-12-01 Intervenciones:
|
Enrolling by invitation |
Nombre del estudio: Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis Condición: Rheumatoid Arthritis Fecha: 2015-12-21 Intervenciones: Drug: tocilizumab subjects will be treated with 162mg of weekly subcutaneous tocilizumab in an open-labe |
Recruiting |
Nombre del estudio: Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab Condición:
Fecha: 2016-11-30 Intervenciones: Drug: Alirocumab Injectable prescription medicine called a PCSK9 inhibitor. |